The expression of calpain-1, calpain-2 and calpastatin was determined in diagnostic core biopsy samples taken from patients with large but operable breast cancer or locally advanced breast cancer who subsequently received neoadjuvant chemotherapy prior to surgical resection. Here, CAPN1 is linked to breast carcinoma.